FindTrial
Sign In

Administration study as a part of research toward the development of detection method for growth hormone secretagogue GHRP-2 in biological samples

Administration study as a part of research toward the development of detection method for growth hormone secretagogue GHRP-2 in biological samples

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080220924
Enrollment
10
Registered
2009-11-20
Start date
2009-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No applicable

Interventions

investigational material(s) Generic name etc : GHRP-2 INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage and

Sponsors

Anti-Doping Laboratory Mitsubishi Chemical Medience Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Weight: more than 50 kg, BMI: more than 18.5 and under 25

Exclusion criteria

Exclusion criteria: Hypersensitivity to drugs, A history of alcoholism or drug addiction, Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug, Supplement, grapefruit or its products, or foods containing Hypericum per-foratum consumed within one week before scheduled administration of the study drug, and Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026